- Location
hypoglycemia
"-
Sandoz Canada Has Recalled Its Health Product Glimepiride Over The Mislabeling of Boxes
Feb 10, 2014Sandoz Canada has recalled its health product glimepiride, which is used to treat diabetes, over the mislabeling of boxes. The mislabeling has occurred on outer carton of the product, which shows as containing 1mg tablets, while the ...
Tags: Glimepiride Medicines, Medicines
-
Children Do Not Benefit From Having Their Blood Sugar Levels Aggressively Controlled
Jan 10, 2014Children who are critically ill after having heart surgery do not benefit from having their blood sugar levels aggressively controlled, but some kids with other life-threatening conditions might, a new study suggests. Experts said the ...
Tags: Blood Sugar, Blood Sugar Control, Ill Kids
-
FDA Has Given Class I Status to a Recall of Abbott Laboratories' FreeStyle Test Strips
Jan 9, 2014FDA has recently given Class I status to a recall of Abbott Laboratories' FreeStyle and FreeStyle Lite test strips, which indicates that the products could cause serious injury or death. Abbott voluntarily recalled the strips because they ...
Tags: Abbott, Recall of Diabetes Products, Abbott Laboratories'FreeStyle
-
Better Diabetes Treatment Has Slashed Rates of Complications in Older Adults
Dec 26, 2013Better diabetes treatment has slashed rates of complications such as heart attacks, strokes and amputations in older adults, a new study shows. "All the event rates, if you look at them, everything is a lot better than it was in the ...
Tags: diabetes treatment, hypoglycemia, low blood sugar, diabetes
-
Commercial Supply Agreement for Liquid Glucagon Rescue Device is declared by Biodel
Dec 19, 2013Biodel, a specialty pharmaceutical company, has announced a long-term supply agreement with Becton, Dickinson and Company, a medical technology company, for worldwide exclusive rights to the novel and proprietary BD Uniject SCF disposable ...
Tags: Biodel, Rescue Device
-
Sanofi Has Released Results of a 24-Week Phase Iiib Clinical Trial
Dec 9, 2013Sanofi has released results of a 24-week Phase IIIb clinical trial showing that Lyxumia (lixisenatide) met the primary endpoint of non-inferiority in blood sugar lowering (HbA1c) when administered to patients either before breakfast or the ...
Tags: Diabetes Drug, Medicine
-
Japan-Based Takeda Pharma Has Received Positive CHMP Opinion
Jul 30, 2013Japan-based Takeda Pharma has received positive CHMP opinion for its three new type 2 diabetes therapies from the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP). The therapies include Vipidia ...
Tags: Therapies, CHMP Opinion
-
Us FDA Issued a Class I Recall of Medtronic'S MiniMed Paradigm Insulin Infusion Sets
Jul 17, 2013The US Food and Drug Administration (FDA) has issued a Class I recall of Medtronic’s MiniMed Paradigm Insulin Infusion Sets. The Paradigm infusion sets are meant for use with Paradigm insulin infusion pumps. These infusion sets are ...
-
Nocturnal Hypoglycemia by Insulin Pump Threshold Edtronic Pause Feature Reduces
Jun 25, 2013US-based Medtronic's sensor-augmented insulin pump with Threshold Suspend feature safely reduces nocturnal hypoglycemia without affecting glycated hemoglobin level (HbA1C), a study results show. Threshold Suspend, which is claimed to be ...
Tags: Health, Medicine, Hypoglycemia
-
The New Weight-Loss Drug Belviq Is Finally Available But You May Not Want to Get It
Jun 14, 2013A year after receiving approval by the Food and Drug Administration, the new weight-loss drug Belviq is finally available by prescription. But you may not want to rush out and get it. It's only approved for people who are obese, with a ...
-
FDA Has Approved Janssen's Invokana for The Treatment of Adults
Apr 2, 2013The US food and drug administration (FDA) has approved Janssen's Invokana (canagliflozin) for the treatment of adults with type 2 diabetes. Invokana is the oral, once-daily medication available in the US demonstrating improved glycemic ...
-
FDA Has Accepted to Review Sanofi's New Drug Application of Lixisenatide
Feb 21, 2013The US Food and Drug Administration (FDA) has accepted to review Sanofi's new drug application (NDA) of lixisenatide, a once-daily a glucagon-like peptide-1 receptor agonist (GLP-1 RA), for the treatment of adults with type 2 diabetes ...
-
NOA Is Granted by Uspto to Hygieia Diabetes Insulin Guidance System Technology
Jan 16, 2013The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Hygieia's claims related to Diabetes Insulin Guidance system (DIGS) technology. The patent covers a system which automatically optimizes a patient's ...
Tags: USPTO, NOA, Hygieia, DIGS technology
-
Dexcom New Continuous Glucose Monitoring System Is Cleared By FDA
Dec 18, 2012The US Food and Drug Administration (FDA) has cleared Dexcom's new continuous glucose monitoring (CGM) system. The G4 PLATINUM system comprises a tiny sensor which is inserted by the user under the skin on the abdomen and a transmitter ...
Tags: Dexcom, continuous glucose monitoring system, G4 PLATINUM system
Related Products
-
Good for Hypoglycemia Luo Han Guo Extract Mogroside V Mogrosides
-
Herb Extract From Natural Hypoglycemic Tea Bag Organic Green Tea Anti Hypoglycemia
-
High-Quality Western Medicine Glibenclamide Tablets 25mg GMP.
-
Metformin Hydrochloride Tablets Used for Obese Type 2 Diabetes and Prevent Hypoglycemia
-
Metformin Hydrochloride Tablets for Patients Treated with Insulin
-
Metformin Hydrochloride Tablets Used for Obese Type 2 Diabetes and Prevent Hypoglycemia
